The Biosimilar Name Debate: What’s at Stake for Public Health

GaBI Journal - Belgium
doi 10.5639/gabij.2014.0301.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pro Pharma Communications International

Related search

Arts Education in Swedish Teacher Training – What’s at Stake?

Australian Journal of Teacher Education
Education
2011English

Feasibility of Opportunistic Disease Prevention: Personal and Public Health Are at Stake

BMJ
2003English

What’s in a Name?

Canadian Journal of Neurological Sciences
MedicineNeurology
1995English

Reality and Reduction: What's Really at Stake in the Causal Exclusion Debate

English

Salween: What’s in a Name?

The Anthropocene: Politik—Economics—Society—Science
2019English

COPD: What’s in a Name?

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2019English

Seromucinous Tumors of the Ovary. What’s in a Name?

International Journal of Gynecological Pathology
GynecologyForensic MedicinePathologyObstetrics
2016English

Modelling, Simulation and Social Network Data: What’s New for Public Health and Epidemiology Informatics?

Yearbook of medical informatics
Medicine
2015English

Tracing the Shifting Sands of ‘Medical Genetics’: What’s in a Name?

Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences
MedicinePhilosophy of ScienceHistory
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy